FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Desvenlafaxine Succinate Tablet, Extended Release
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Pfizer Inc. (New 09/11/2023)

Company Contact Information:
800-533-4535

Presentation	Posting Date	Related Information
Pristiq, Tablet, Extended Release, 100 mg (NDC 59762-1222-3)	06/20/2023	Discontinuation of the manufacture of the drug; Supply expected to exhaust late July 2023
Pristiq, Tablet, Extended Release, 50 mg (NDC 59762-1211-3)	06/20/2023	Discontinuation of the manufacture of the drug
Pristiq, Tablet, Extended Release, 25 mg (NDC 59762-1210-3)	09/11/2023	Discontinuation of the manufacture of the drug; Supply expected to exhaust November 2023